#389 Dexcom CEO, Kevin Sayer

October 3, 2020Scott Benner

Fireside Chat

Dexcom CEO Kevin Sayer is back to chat about type 1 diabetes.

You can always listen to the Juicebox Podcast here but the cool kids use: Apple Podcasts/iOS - Spotify - Amazon Music - Google Play/Android - iHeart Radio - Radio Public, Amazon Alexa or their favorite podcast app.

+ Click for EPISODE TRANSCRIPT

DISCLAIMER: This text is the output of AI based transcribing from an audio recording. Although the transcription is largely accurate, in some cases it is incomplete or inaccurate due to inaudible passages or transcription errors and should not be treated as an authoritative record. Nothing that you read here constitutes advice medical or otherwise. Always consult with a healthcare professional before making changes to a healthcare plan.

Scott Benner 0:00
Hello friends and welcome to Episode 389 of the Juicebox Podcast. I have a treat for you. Let's welcome back the CEO of Dexcom, Kevin Sayre. Kevin and I are going to have a pretty chill about 30 minute conversation where we go over a number of things that are going on at Dexcom. It was really was nice. And Kevin and I have talked to each other so many times, it just felt easy. And I think that reflects in the conversation.

This episode of the podcast is not sponsored by anybody. So there won't be any ads. Just a few reminders. First reminder, the T one D exchange, once you to join their registry, T one d exchange.org. forward slash juicebox. You've heard me talk about it on other episodes, get in there, find out what it's about. It is not an ad t Wendy exchange has not bought an ad on this podcast. I do however, get you know, a couple of bucks for every one of you that signs up. So if you're looking for a way to support serious Type One Diabetes Research, while you know kicking a couple dollars back to your friend Scott T one d exchange.org. forward slash juice box. Here's some other stuff. You're looking for a great doctor to help you on your journey with Type One Diabetes, where you have one to share with other people, please go to my page juicebox docs.com, give a penny take a penny, give a doc take a doc, let's build a great list for people to use. And if you're looking to share those pro tip episodes with other people, you can of course send them back to Episode 210 of the podcast where they can start. Or they can head over to diabetes pro tip.com. The pharmacy for veterans. That's new. And that

Kevin Sayer, Dexcom CEO 2:09
is new for us.

Scott Benner 2:10
It seems very comprehensive for who it's helping.

Unknown Speaker 2:14
It is okay.

Scott Benner 2:16
How does it work? What what so any veteran goes into where How do they do that.

Kevin Sayer, Dexcom CEO 2:21
The VA system is one of the largest health systems in the country. And as a population, one in four veterans ends up with diabetes. And and so this is a group that really, we felt could use our sensor. The coverage is very similar to Medicare with respect to its intensive insulin users who get to CGM now on multiple daily injections or a pump. But the fact that we can now they can get it through their pharmacy channel rather than all the DMV paperwork that that many of our patients have to go through. As we work on simplifying a distribution channel, this was a great win for us. And we think a great win for veterans.

It'll be great for that group.

Scott Benner 3:06
And if I'm looking correctly here, you don't to get coverage. I'm seeing need to have diabetes, you require insulin, an insulin regimen of more than three injections a day or an insulin pump. Yeah, so it's low level here. Yeah,

Kevin Sayer, Dexcom CEO 3:24
it's low level and there is no copay. That's great. They just go get it. That's amazing. Yeah, it's a really good arrangement.

Scott Benner 3:32
Excellent. And that's just any. So veterans listening will know what a VA pharmacy is, or is there a way

Kevin Sayer, Dexcom CEO 3:38
they will know if they're on a VA health plan? Yes, gotcha. They'll understand that

Scott Benner 3:43
that's really astonishingly exciting. Especially because it's not just I think it's easy to think of veterans, right as older people, but there's plenty of people who are much money.

Kevin Sayer, Dexcom CEO 3:54
There's plenty of people in that system.

Scott Benner 3:56
Yeah, no kidding. Oh, and there's a link here. I'm gonna. I'll link to it so that people can go right to it. That's excellent. That is really exciting. The last time you were on, we talked a lot about COVID, bringing Dexcom sensors into hospital situations. And that seems to be growing from there. Can you tell me where it's gone?

Kevin Sayer, Dexcom CEO 4:18
Yeah, I can. You know, we were contacted by more than 200 hospitals and we've got into more than 100 of them in various degrees. bringing new technology to a hospital is never simple. And bringing new technology to a hospital pandemic, isn't. That's even a bigger challenge. We've learned a great deal. I tell you, the first learning is why our product will function and do very well in that environment. You know, in the beginning, and one of the reasons we didn't have a labeled indication there is if you go way back in sensor days, there were interferences that could cause the sensor we had an acetaminophen contraindication For example, which we don't have anymore, we have an interference layer on our membrane. So there was a perception that these things wouldn't even work in the hospital. And the FDA, in all fairness wanted us to do some more work, we'd spoken with them about hospital indication, for years, do some more work to make sure that that interferences didn't cause the sensor to be wildly variable. But when you had several hospitals back east, where diabetes and COVID were converging, and people had good knowledge on the diabetes side, we were getting flooded with phone calls. And I believe the FDA was getting flooded with phone calls, too. So we got that non enforcement, discretionary non enforcement waiver, go do this, we will let you go play in the you know, go be in that market and see what we can learn. And it's got the experience when we started, you know, based on the phone calls, it literally looked like our entire inventory has been going to the hospital because people wanted so many sensors. And then as we started getting through this, you're training ICU people to do something, use a product that we designed for patients to use in their homes. And, and so we had to figure out how to make it work in that environment, we purchased a whole bunch of phones, because the hospital doesn't have fun playing around and they don't want their healthcare professionals carrying around their own phones, with patients data on it. So we purchased phones, to get the data to the cloud, then you've got the whole internet and connectivity issues in hospitals, because they have very strict HIPAA requirements. And so we've walked through all those things to get everything figured out. And what we've learned is our product can have a big impact, it cuts down on pp. Significantly, it cuts down visits in the room. Now the care professionals don't have to go in the room of the people with diabetes and stick their finger, it really can be used to eliminate one of the things that can advance the disease, because if your body is fighting high glucose values, and oftentimes these patients it was in the foreign 500 range. Combined with respiratory issues, your immune system can't fight both. It just can't. And so if we can eliminate the diabetes, variability from it, that is very helpful. We need to get this data from the hospitals to show what we achieved here. And what we've learned. We want to take it, we want to build a file, we want to get back to the FDA and say, you know, this is what we've learned here, what are our next steps in creating a hospital application, the other learning on our so that's why we have the registry, we wanted an organized manner where data could be kept private and secure. Hospitals would be comfortable getting data to us. And we can compile the registry and then go to the FDA and say this is what we learned. This is the data we had this is the profile the patients. This is the compounds they were on when they were in the hospital. Here's how quickly they got out all those types of things and use it as a base. We think CGM in the hospital could provide wonderful benefit if you walk around a cardiology ward. And and and ask how many these patients have in particular type two diabetes as they get older. The numbers are pretty staggering. If we can control the diabetes part better. I mean, I've been in IC use, where if a patient has diabetes, there's 48 finger sticks a day. So a nurse has to walk in, stick their finger 48 times a day, every half hour, all night long. We put a CGM on that patient voice. They count much time and money that saves the system. And not only that, let somebody do the job they they signed up to do give care to patients rather than

Scott Benner 8:49
just checking and checking,

Kevin Sayer, Dexcom CEO 8:50
just checking and checking. So we think there's a really good opportunity here and we'll learn from the registry registry, what we're learning from our experience. I had to just shut my phone off. I'm sorry. And we'll be good. So it's, it's pretty exciting there. You know, there's good stories. And you know, one doctor told us a story about a patient who they were about to ventilate, but when they got under control with CGM, they didn't have to. It was the high blood sugars causing the patient could fight off the corona if they weren't trying to fight their high blood sugars. And I think there's a correlation to all these things.

Scott Benner 9:30
Well, I have a personal anecdote, I guess that I've never shared on the podcast before but my father, as an older man had congestive heart failure type two diabetes, but he fell and just kind of slipped off a chair actually and gashed his his shin badly enough that it wouldn't heal and he ended up in the hospital where I watched them ignore his blood sugar. Like it just wasn't a factor in his care. And he did. In fact, he passed away about a week later and You know, I realized he was not in great health to begin with, but he was not, you know, he was not on death's door prior to cutting his leg. And once he got into a hospital setting, I would tell him, I'm like that they're not they're not managing your diabetes. And he's like, they say, it'll be okay. They want it to be high. They don't want me to get low. And I couldn't talk him out of it. I couldn't talk him out of believing that his his body's ability to, to heal was directly related to you know, was compromised.

Kevin Sayer, Dexcom CEO 10:28
Yeah. Yeah, I had a very similar experience with my mom, she had a heart valve replaced and literally she couldn't leave the hospital because her blood sugar's were so high that because the heart valve operation didn't work base, the stress and anxiety in her body from that surgery. That's what they they couldn't fix. And I'm sitting up there. As I think it was right after I started, not long after I started Dexcom. I'm sitting there going, I can fix this. But yet I couldn't. And so I think someday we have a really good answer here.

Scott Benner 11:05
Yeah, no, institutionally, I think that this has a significant possibility of changing the way minds work around blood sugar management, while people are in the hospital.

Kevin Sayer, Dexcom CEO 11:15
And Scott, my other learning here, and this is, you know, this just goes to Dexcom. And how we work, we need to create the proper experience in the hospital for the caregivers. And for the patients. We are all about the experience for the customer and for the patient. And and one of the big learnings is taking a product that's meant to be used by you and your daughter at home. And and day to day isn't necessarily the same workflow, and visualizations and communications, as one of the one the hospital and one of the challenges. I've given the team after this experience. And with this registry, let's create the right thing. Let's create the right experience for this environment. So the product can be used when you create the right experience. No one's going to use the product even it's perfect anyway. Right. And so I think long term, that's another thing that comes to this, we will create the absolute right. Right experience for that environment.

Scott Benner 12:13
I'd also be interested to see how those two different uses end up feeding each other, like what will you learn in the hospital that will help the home user? What will you learn at home that helps the hospital use that? Yeah, I think that would would prop itself up?

Kevin Sayer, Dexcom CEO 12:28
I agree with that. Yeah.

Scott Benner 12:31
Okay, so I wanted to ask you, then about you guys are doing something with the University of Virginia about research, but I don't understand what it is.

Kevin Sayer, Dexcom CEO 12:38
That's okay. I'm happy to answer that question. You know, the week acquired a company called type zero back in 2018. They're the group who developed the and control study. And then the the algorithm, the control IQ algorithm used by tandem in that system. And the scientists, some of the scientists who were part of that remained at the University of Virginia, and there's a lot of knowledge. And a lot of great thought there. As far as what we could do in the future with diabetes. We felt the thought and the skills of these of these scientists at that university, combined with the people we had in Virginia would give us a great opportunity to create more tools for our patients in the future. And we wanted access to those guys. And we wanted to make sure that the group was funded, and really could continue to work with us. So that that's why we signed the agreement really, is to continue to develop more tools for our patients.

Scott Benner 13:35
And so they're just going to its research center, then like

Kevin Sayer, Dexcom CEO 13:39
three, its research center, and we will do research and develop, develop future applications for our technology with them

Scott Benner 13:45
for type one and type two, I'm guessing. Yep. Okay. That's where it

Kevin Sayer, Dexcom CEO 13:50
is open to where whichever directions, they think they can help us or directions that we would like to go.

Scott Benner 13:57
That's excellent. Well, I guess you guys are pretty busy in house doing what you're doing. And so this is sort of just another avenue, right?

Kevin Sayer, Dexcom CEO 14:05
You know, what, there are a lot of smart people out there who are trying to solve these problems. And to the extent we can have good relationship ships with them, and we're bigger now. I mean, there is some advantages to size five years ago, I didn't have a million dollars a year to commit anything to university. Now we do, right, and so and I don't even know what the financial terms are, I'm speaking a bit out of turn, right. And all that but but you know, where I'm headed, we really didn't consider ranges like this because we were so focused on managing our cash and everything. So through size and scale, we're able to do more and I think this is a really good investment on our part. We look we think there's going to be great things come out of this.

Scott Benner 14:45
Excellent. That's exciting. Okay, so 2020 as we all know is not been very exciting. Everyone's excited to get to 2021. I just for so many reasons that aren't aren't worthless thing, but I'm wondering what that Users should have to look forward to coming up.

Kevin Sayer, Dexcom CEO 15:05
Continued innovation, continued growth and support, I think our technology pipeline is, is still incredibly robust. So what we have coming. And what we have today, I mean, you know, let's not forget, we're only two years into GE six of these devices usually have a life cycle longer than two years. And we made a commitment to go faster and accelerate that lifecycle by moving to G seven, where literally every component of the system is different than what we do did with G six. So we'll continue to improve GE six, we have algorithm updates, we are, you know, looking at finer things like updating the share system, that user interface over time, we'll continue to refine that experience, we're very focused on G seven, we're back in the clinics, we're not giving g seven timelines, because I just can't give our playbook to everybody. But in the short term, g six really gets a lot of good things. And I think another one of our big efforts is just improve access for patients. I had a call yesterday, you know, and I get emails as you do, and most of my emails from patients do not relate to the product. Other than we'd love the product, it's I am having a hard time getting this and this guy was a hospital administrator. And he'd been in health care for 30 years. And I said, You know what, I'm gonna take this one and spend a little time on the phone. And it was a great conversation. And, you know, he said, I don't know how, and he was late in life, having used the product, I don't know how anybody would even manage this without it. I it's beyond me. So we want to create that experience and get more people access to the system. And his problem was very simple. He's on this auto ship plan every 90 days and insurance only let him order exactly 90 days later. And if if for some reason he runs out of sensors, even if they all last 10 days, he's days without. And, you know, he wanted to ask how are you going to solve that problem for me and we had a great discussion about it. He understood rise Kevin from and we we got them taken care of and gotten injured. But I think more access, getting to more people continuing to technology pipeline. And just, you know, having this needs to really become the standard of care, not just in the US but everywhere. And I think we've made great advances in us, we're looking at our international markets, how do we get more visible and more access in in more international markets, and I've personally challenged, the team must go be more aggressive, let's go get more people on this technology, because once they use it to God, they don't. Their lives are changed forever. It's 100%. True,

Scott Benner 17:59
I my first thought when you were talking was will the marrying for like, you know, control IQ on the pod five, that kind of stuff. Will that cause the insurance companies to believe that there can't be a lapse in me having a sensor right, because now my pump. Also, you know what I mean? Like is connected that the other thing is to I am, you know, as humbly as I can say this, I'm really very good at diabetes. And then if you take that data away, I become very average at it pretty quickly. And it's not that my daughter goes from you know, an average daily day of like 5581, c two a 12. But suddenly, we can't be as aggressive with meals as we'd like to be we can't be as fine with bagels as we'd like to be and then everything starts drifting the wrong way. You get very up and down. And before you know it, you feel very lost.

Kevin Sayer, Dexcom CEO 18:52
Well, I liken it, what kind of COI B with no data. Yeah. How could you possibly run a company without knowing where we are? right and so I don't need to know where we are we five minutes so I I can take peaks a little a little later. But no, I you can't you couldn't. And I you know, the insurance companies It is really interesting is as I talk to some of these guys they are so there are so many brilliant people there. But as you look at the hundreds of thousands, if not millions of people they have to take care of then you get down to the number of people that use our sensor. Yeah, absolutely. Gee, if I'm approving this pump that's dependent on the sensor, we shouldn't be waiting, we shouldn't have any problems. But by the time you get down to the number of people that is versus the number of people they take care of. Yeah, it's it's really hard for them as business people. Just to understand how all that works. And and I we've looked at models, Scott So I'll give you a perfect example. What if we sent an extra box to everybody just so that never happens? And you know what happens if I do that? They just use the box instead of place to next order. Oh, okay, most of them. And then then we run out anyway. And three months later, we've got that problem. And we sent a free box of sensors that cost us money that we didn't get revenues for, that the insurance company didn't have to pay for. And so I have come up with every mathematical model, and Chen, our marketing organization would tell you, I'm somewhat relentless on this. And I really haven't come up with anything simple.

Unknown Speaker 20:43
So you run into

Scott Benner 20:45
the failings of people. At some point,

Kevin Sayer, Dexcom CEO 20:47
you run into the and the failings of us as a company and the failings of our distributors, and the failings of drugstores and the thing, the biggest problem is getting this to people in an efficient, easy manner. It's almost, I would love to say we have it down. And we're a lot better than we used to be. We've made tremendous inroads here. But there's there's still more to go here and and you know, are pushed to the pharmacy to get this thing covered. As a pharmacy benefit. In most places

Scott Benner 21:19
you made me we, I'm sorry. Yeah,

Kevin Sayer, Dexcom CEO 21:22
we had, we now have more of our new patients come through the pharmacy than come through the the other channels now, which means they're giving it to the drugstore, and the copay at the pharmacy level. And James can get you the we can get the exact numbers, but a large percentage of I want to say 30% has zero copay. Oh, wow. If we can get him to that channel. So we have done our best as a company to make it more accessible and, and literally, that access been willing to compromise on on pricing. Because if our patients can get it easier, happy, guess what, they buy more, they're loyal and everything is good. It makes perfect business sense. Now

Scott Benner 22:01
I've seen incredible, you know, strides from you guys over the years for certain it's funny you you were talking about what would happen if I just gave everybody an extra box, you made me think about a buddy that we had in our 20s, who was always stressed out about not having money. And so I came up with this idea of us all throwing a little bit of money into a bank account for him. So that he had a cushion to take away that stress. Then we did we collected about 500 bucks, all of us and we we we put it in his bank account, and he spent it.

Unknown Speaker 22:30
And I was like, oh,

Unknown Speaker 22:33
we're trying to take your stress away.

Kevin Sayer, Dexcom CEO 22:35
Human nature.

Scott Benner 22:36
Yeah, it's just how it is? I think so. I really do. Oh, before I forget to mention this, and we run out of time, it's such a small thing. But a number of people asked me to tell you that the the process of ordering overlay patches is not probably as seamless as you hope. Yeah. So so I won't have

Kevin Sayer, Dexcom CEO 22:55
that on.

Scott Benner 22:57
Yeah, that was it. Nobody really I said, Hey, Kevin is coming on. They're like, tell them we want that overlay patch link to work better. And I was like, and everything on the UI side is great.

Kevin Sayer, Dexcom CEO 23:06
If this is your toughest user group question for me, man. It's over people. If you're listening to this podcast, you can do better than that

Scott Benner 23:14
come up with better questions. No, they, they just all seem kind of a happy accident. I mean, listen, not for nothing. Everybody wants to know when the g7 is coming. And I think that that ebbs and flows online, when someone discovers an image of it and reshares it as if it's, it's a new idea. And then it kind of gets everybody lit up again. But I agree with what you said earlier, I have a hard time arguing with you. I'm using g six with Arden. And it's been terrific. And it's been

Kevin Sayer, Dexcom CEO 23:42
it's a spectacular product. And we've tried to address in G seven, all the things that we can make better. But it's g six is really good. You know, I was talking I was reminiscing a bit the other day, as you look at the things we brought to market, the Dexcom in bringing connectivity directly to the phone and all these integrations the way we designed g six, you know, we made a commitment back in G five Scott and you appreciate the technology, we put a processor in the transmitter to whereby all we're sending to that phone app or to your pump or whatever is the number. So we can integrate across multiple platforms, we can communicate with multiple devices at the same time. The thought that went into some of these things, delayed technology for a long time. But we think we're gonna give the patients the opportunity to have the technology and the things that they want to sharing. Uh, you know, I got my first email on sharing data three days. After you remember the g4 receiver I've heard I don't remember what we call it, but the g4 receiver that would talk to the phone. Sure. And I mean three days into that I got an email from somebody saying we'd save their life. The proactive alerts and a lot you know, the the low glucose soon alarm. I think the numbers like 4 million patients have acted on a low glucose soon alarm and avoided a low glucose value, right at some point in time in the night. Those are our four main instance. Those are big innovations and big changes, and we'll continue to bring those to market. So yeah, again, listeners, don't sleep on Dexcom will be there.

Scott Benner 25:27
Well listen, if you're making me think of two things. So the The first thing is, and and maybe I can take your challenge up here. I could do a a focus group online. And then bring it out like this. If you want to hear people's ideas like do you just want to hear people's ideas? Or do you think you've had the advice that I

Kevin Sayer, Dexcom CEO 25:46
hear quite a few of them? Yeah. But I'm not averse to. I don't know if I'd want to do an online or have a discussion. But I am happy to address anything on a podcast like this. Yeah, we have, we have spent a lot of time listening over the past couple years. I'd like to say we're a lot better than that than we used to be. We used to be a bunch of scientists. Yeah, figuring out this is what we can do. Now our scientists, in addition to our consumer, people become listener. So we do a lot of focus groups and listen, but if you I mean, we could talk about that offline.

Scott Benner 26:21
But I'll bring it to you. I can go on Facebook and get everybody's thoughts and then just dump them in your lap. And inundate you with them if you want to.

Kevin Sayer, Dexcom CEO 26:30
My favorite user discussion was with an 11 year old who for his vacation came to San Diego, parents from San Diego, he had three pages of notes on a legal pad. He had questions about the chemistry, the chemicals used in the membranes. He had studied this so much it was it was an awesome us morning, I was blown away. That's cool. Why this kid? So Well, listen, and if you have some to bring me I happy to, we may or may not address them all, but I'll certainly listen. No, it'd be.

Scott Benner 27:00
It's interesting, I think just to hear, like, you know, down to the smallest idea. For instance, like people are like, I'd like to be able to set like a different alarm for a different time or I need a different tone sometimes or just the just the idea of what make wood in a perfect world make their their experience better. Maybe some of them are addressable, and maybe some of them aren't. But it might be something you haven't thought of. I am going to let you go. But let me ask you, because you said something a second ago about the chip being able to talk to more than one device, which leads me to ask you about right from the transmitter to Apple Watch. Because that is something people ask me about a ton.

Kevin Sayer, Dexcom CEO 27:37
That project is not going as fast as we wanted our Bluetooth radio is needed to evolve an Apple Watch technologies also evolved a bit, I think with I'm very confident will be there with G seven, I don't know where that progress is G six wise or with the next generation watch. Next, something, we'll just have to get back to you on it. It is moved, it's moved back on the list, because we've just had to deal with some other mainly getting g7 ready to go and that Bluetooth has taken priority over the direct to watch connection. Yeah, I bet I get it. I get and I get why people want it. There's a lot of complexity there. Because that watch has to be charged every day or every other day. And then the question is, what do you do for loosen alarms while the watch is charging? And what is it going to talk to? And there's some things we have to work out?

Scott Benner 28:24
Yeah, I think that's been a through line through a lot of things we've talked about today is that there's more going on, than maybe the average person would expect. It's not just so easy to throw Dexcom into a hospital and let them use it, etc.

Unknown Speaker 28:35
That kind of No, not at all. Yeah,

Scott Benner 28:37
well, I appreciate this, Kevin very much. Your time is always well appreciated by me. So

Kevin Sayer, Dexcom CEO 28:43
hey, thanks for having me again. Of course. I'll see you soon. You bet. Bye Bye. Take care.

Scott Benner 28:50
I always enjoy talking to Kevin and find out what's going on at Dexcom. Big thanks to him for coming on the show. Here's some other stuff T one d exchange.org. forward slash juice box. Go check it out. I joined the register. You can too. If you're a US citizen, and you have type one diabetes, or a US citizen who is the parent or caregiver of someone with type one. And you can jump right on. I answered every one of their very simple questions in less than 10 minutes, you could do absolutely the same. Just check it out. See what you think T one d exchange.org forward slash juicebox. Their research has brought some pretty amazing things to light for people with type one diabetes, and I would not be talking about them if I didn't believe in what they were doing. Don't forget again juice box docs.com if you're looking for a great doctor, or you'd like to suggest one to one of the other listeners of the podcast, and of course those diabetes pro tip episodes are right there in your feed. They begin at Episode 210. There's also for new listeners or people are just jumping on All of the Ask Scott and Jenny episodes are defining diabetes episodes. If you're really looking for management talk, this is where you go diabetes pro tip, defining diabetes, and ask Scott and Jenny, I think all of the other episodes are absolutely terrific. But if you really want to dig down and look at management talking about insulin, that's where you start. Look, I have a little time left here, so don't begrudge me if I tell you that, while this episode is not sponsored, there are sponsors of the podcast that you could visit and there are links in the show notes of your podcast player at Juicebox podcast.com. If you want to find out more about the Dexcom g six continuous glucose monitor, get a free no obligation demo of the Omni pod tubeless insulin pump find out more about g volt glucagon the Contour Next One blood glucose meter and touched by type one.org. And I already mentioned to you on the exchange. So anyway, look, I put this episode together for you on a Friday night. So don't don't hassle me. Let me just get out there and click on the links. Help me out a little bit, though. Wait, I'm back. There was something else? Hey, sorry. I apologize. I the abrupt stopping and starting may have been confusing. You should check out the private Facebook page. For the podcast. It's really something else. I'll let you decide if that's true or not. But it's called Juicebox. Podcast. Type One Diabetes. It's a private Facebook group has over 6000 users right now. And it might be the nicest place online to talk about type one. Really proud of the people that are there. Boom, boom, boom. Oh, you're loving the show. leave a review. I was a good one. Right on Apple. Right? Five stars say something really heartfelt. Nice. Spell all the words, right? Because it means less when you make a typo. I don't know why. But when you're reading like us a really great review. This person really loves us. Oh, they spell three words on? Yeah. Geez. Not as great. You don't mean just proofread it. I know. Now I'm asking you to leave a review and proofread it. But I mean, that's pretty much the minimum effort on that, don't you think? What else there's got to be something else. It's late on Friday night. spent the whole day putting together a bed for art and my knees hurt. I was like on the floor in the garage. And I gotta be honest with you. I feel like I'm gonna really feel it tomorrow. These are not your problems, but they are mine. And I am the one talking to the microphone. So I pretty much get to do whatever I want.

What else should I be saying to you guys? Hey, follow me on Instagram, too. If you uh, you know, if you're on Instagram, it's at Juicebox Podcast. That's pretty much it. You know, one last thing. A lot of people listen to the podcast online, which is cool. Like, if you want to listen on my website is fine with me. It's just, there's so many easier ways to do it. So I thought I'd go over them very quickly for people who end up listening to the show and don't know a ton about podcasts. First of all, if you have an iPhone, you just open the podcast app from iPhone search Juicebox Podcast, and then subscribe to it. Now be careful make sure you get Juicebox Podcast type one diabetes, because after this podcast got really popular. A lot of people had the idea to call their podcast that Juicebox Podcast they're trying to trick you into listening to their podcast, but don't do that. Listen to mine. Juicebox Podcast type one diabetes, search it right there in the app on your iPhone. The app is called podcasts. So it can't be that difficult to find. You can also listen on Google Play. We're brand new on amazon music. You can listen on amazon music now. Pandora, Pandora, people like Pandora, right? Stitcher, I Heart Radio, you can even say to Alexa to play the show. Oh, and Spotify. Right? Spotify is a place where a lot of people listen to things. So that's a place you should know about to in honesty, pretty much any of these applications that you've ever heard of. You can find the podcast and please remember, especially Android users who have to use a lot of third party apps for podcasts, you should not have to pay for a podcast app. Okay, there are good ones out there that are free. Actually at the top of Juicebox Podcast calm. It says subscribe and listen for any podcast app. As you kind of scroll through the different things you can click on. There's one that says subscribe on Android. And that just takes you to a page that shows you a ton of different podcast apps for your Android phone. podcast addict is very popular with people I hear people like pod kicker. Anyway, there's a lot of different players pick one don't pay for them was my point. podcast app should not cost money. This should never cost you any money. Spotify said actually, too, for those of you living overseas. Ghana, I think is an India based app. Starting to get some listeners there, so hey, Andy, what's up? You can also listen on player Fm radio.com and Deezer. I don't know what these are is, but I'm on Deezer. Alright. And these are the places you could listen to the podcast. Yeah, that was that was lame, lame, but I enjoyed it. And anyway, find the show on a podcast player and subscribe. It really is the easiest way to listen unless you love listening online and then Okay, do that. I'm not stopping you. It's cool. But you know, podcast players keep your place while you're listening so you can come back to shows it's a lot easier. Is that it? Alright guys, I'll see you. When I see you. Which will be sometime next week. We will be more episodes, the Juicebox Podcast. Thanks a lot for listening. I really, genuinely appreciate your time.